Pharmaceutical interventions for emotionalism after stroke

Stroke

Volumn 35, Issue 11, 2004, Pages 2610-2611

  Horrocks, Judith A ^a   Hackett, Maree L ^b   Anderson, Craig S ^b   House, Allan O ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

CONFERENCE PAPER; CRYING; EMOTIONAL DISORDER; HUMAN; NONVERBAL COMMUNICATION; PRIORITY JOURNAL; RANDOMIZATION; STROKE;

AFFECTIVE SYMPTOMS; ANTIDEPRESSIVE AGENTS; CEREBROVASCULAR ACCIDENT; HUMANS;

EID: 7644233761     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000145291.71063.94     Document Type: Conference Paper

References (6)

1. Andersen G, Vestergaard K, Riis JO. Post-stroke pathological crying or emotional affect treated with citalopram a selective serotonin reuptake inhibitor. Acta Neurol Scand. 1994;89:151.
2. Brown KW, Sloan RL, Pentland B. Fluoxetine as a treatment for post-stroke emotionalism. Acta Psych Scand. 1998;98:455-458.
3. Burns A, Russell E, Stratton-Powell H, Tyrell P, O'Neill P, Baldwin R. Sertraline in stroke-associated lability of mood. Int J Geriatric Psych. 1999;14:681-685.
4. Ohkawa S, Mori E, Yamadori A. Treatment of pathological laughing with amitriptyline. Clin Neurol. 1989;29:1183-1185. In Japanese.
5. Parikh RM, Robinson RG, Lipsey JR, Price TR. Nortriptyline treatment of post-stroke emotional lability a double blind study. Neurology. 1989;5(suppl 1):177. Abstract.
6. Robinson RG, Parikh RM, Lipsey JR, Starkstein SE, Price TR. Pathological laughing and crying following stroke validation of a measurement scale and a double-blind treatment study. Am J Psych. 1953;150:286-293.